Financial results - CITOMED SRL

Financial Summary - Citomed Srl
Unique identification code: 16905375
Registration number: J12/3929/2004
Nace: 8622
Sales - Ron
27.628
Net Profit - Ron
19.373
Employee
1
The most important financial indicators for the company Citomed Srl - Unique Identification Number 16905375: sales in 2023 was 27.628 euro, registering a net profit of 19.373 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Citomed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 40.610 40.534 40.738 38.125 27.515 31.900 33.506 27.628
Total Income - EUR - - 40.610 40.534 40.738 38.125 28.089 31.900 33.506 27.628
Total Expenses - EUR - - 869 183 326 1.854 5.470 6.293 7.046 7.984
Gross Profit/Loss - EUR - - 39.741 40.351 40.412 36.271 22.619 25.607 26.461 19.644
Net Profit/Loss - EUR - - 38.523 39.135 39.190 35.314 22.364 25.295 26.176 19.373
Employees - - 0 0 0 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -17.3%, from 33.506 euro in the year 2022, to 27.628 euro in 2023. The Net Profit decreased by -6.724 euro, from 26.176 euro in 2022, to 19.373 in the last year.

Check the financial reports for the company - Citomed Srl

Rating financiar

Financial Rating -
Citomed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Citomed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Citomed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Citomed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Citomed Srl - CUI 16905375

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 0 0 519 306 100 0 0 0
Current Assets - - 39.439 54.257 41.844 35.833 56.064 27.665 72.848 27.661
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 3.345 2.402 2.442 2.580 2.695 3.259 23.729 4.375
Cash - - 36.094 51.855 39.402 33.253 53.369 24.405 49.119 23.286
Shareholders Funds - - 38.567 39.835 39.613 35.596 24.187 27.112 26.403 26.895
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 871 14.422 2.750 542 31.978 552 46.444 766
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 27.661 euro in 2023 which includes Inventories of 0 euro, Receivables of 4.375 euro and cash availability of 23.286 euro.
The company's Equity was valued at 26.895 euro, while total Liabilities amounted to 766 euro. Equity increased by 572 euro, from 26.403 euro in 2022, to 26.895 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Citomed Srl

Comments - Citomed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.